代谢重编程在非小细胞肺癌进展中的新兴作用
Beatriz P Peixoto1, Rebecca A Clague1, Joshua P Reddy1
1Department of Pathology, University of California San Diego, La Jolla, CA 92037-0695, USA.
Frontiers in bioscience (Landmark edition)
|August 6, 2025
概括
代谢重编程推动非小细胞肺癌 (NSCLC) 的进展和治疗抵抗. 针对癌症特定的代谢途径对于开发有效的肺癌疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 分子生物学分子生物学
背景情况:
- 肺癌是癌症死亡的主要原因,通常以转移和治疗抵抗为特征.
- 目前针对晚期非小细胞肺癌 (NSCLC) 的治疗方法面临挑战,原因是获得的抵抗机制.
- 代谢重编程越来越被认为是NSCLC进展和生存的关键驱动因素.
研究的目的:
- 审查最近在了解NSCLC中的代谢重编程方面的进展.
- 突出代谢异质性和适应在NSCLC进展中的作用.
- 讨论在NSCLC治疗中准代谢途径的挑战和未来方向.
主要方法:
- 关于NSCLC代谢的临床前和临床研究的文献综述.
- 对瘤基因突变及其对NSCLC代谢途径的影响的分析.
- 检查NSCLC细胞及其微环境之间的代谢交叉.
主要成果:
- NSCLC细胞表现出异质的代谢途径激活,受瘤突变的影响.
- NSCLC细胞的代谢表型在环境和治疗压力下演变.
- 在初级和转移部位均观察到代谢适应,促进了生存和与微环境的交叉交流.
结论:
- 准代谢途径对NSCLC治疗有希望,但仍然存在挑战.
- 许多向代谢疗法在临床试验中失败,原因是它们对正常细胞的非向作用.
- 未来的研究应该专注于制定策略,选择性地针对NSCLC中癌症特异性代谢脆弱性.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
9.4K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Regulation of Metabolism
9.9K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
